ArticleCancer immunology, immunotherapy : CII2007

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients.

Alfred Zippelius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.